Ulrich is an expert experienced in developing drug candidates from research through nonclinical development into early phases of clinical development. Graduated with a PhD in immunology and completed 10 years academic research at the German Cancer Research Center in Heidelberg, Germany and the Dana Farber Cancer Institute in Boston, MA, USA, with focus on immune cell function and immune oncology.
Before joining SOTIO in 2016 he worked 19 years in German Biotech companies such as MediGene, Morphosys and Pieris with responsibilities for nonclinical development, project management and entire R&D activities. He was responsible for nonclinical packages of different drug candidates, including small molecules, cell vaccines, and biologics, enabling the initiation of clinical development in mainly oncology but also auto-immune indications. Early clinical development activity in managing phase I/II studies complements his experience.